16-88646842-G-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_000101.4(CYBA):c.204-4C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000172 in 1,611,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000101.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYBA | NM_000101.4 | c.204-4C>A | splice_region_variant, intron_variant | ENST00000261623.8 | NP_000092.2 | |||
CYBA | XM_011522905.4 | c.204-4C>A | splice_region_variant, intron_variant | XP_011521207.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYBA | ENST00000261623.8 | c.204-4C>A | splice_region_variant, intron_variant | 1 | NM_000101.4 | ENSP00000261623.3 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000200 AC: 50AN: 250288Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135558
GnomAD4 exome AF: 0.000168 AC: 245AN: 1459608Hom.: 0 Cov.: 34 AF XY: 0.000157 AC XY: 114AN XY: 726278
GnomAD4 genome AF: 0.000210 AC: 32AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74300
ClinVar
Submissions by phenotype
See cases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Jun 24, 2020 | ACMG classification criteria: PM2 - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 22, 2016 | - - |
CYBA-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 06, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at